UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Alibaba
BABA
|
+$2.55B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$459M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$316M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$293M |
| 5 |
GSK
GSK
|
+$251M |
Top Sells
| 1 |
Stellantis
STLA
|
+$991M |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
Apple
AAPL
|
+$315M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 5 |
Intel
INTC
|
+$283M |
Sector Composition
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 8.49% |
| 4 | Healthcare | 7.86% |
| 5 | Industrials | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Akero Therapeutics
AKRO
$3.63B
| $830K | ﹤0.01% |
28,609
+22,455
| +365% | +$651K |
|
3527
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$2.91B
| $829K | ﹤0.01% |
31,726
+2,083
| +7% | +$54.4K |
|
3528
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$2.92B
| $828K | ﹤0.01% |
14,751
+10,353
| +235% | +$581K |
|
|
OGCP
3529
Empire State Realty Series 60
OGCP
$2.04B
| $827K | ﹤0.01% |
74,288
+71,180
| +2,290% | +$792K |
|
|
NIQ
3530
DELISTED
NUVEEN INTERMEDIATE DURATION QUALITY MUNICIPAL TERM FUND
NIQ
| $827K | ﹤0.01% |
56,441
-1,342
| -2% | -$19.7K |
|
3531
BioLife Solutions
BLFS
$1.24B
| $826K | ﹤0.01% |
22,943
-41,233
| -64% | -$1.48M |
|
|
FLC
3532
Flaherty & Crumrine Total Return Fund
FLC
$187M
| $825K | ﹤0.01% |
33,836
-908
| -3% | -$22.1K |
|
3533
Varex Imaging
VREX
$514M
| $823K | ﹤0.01% |
40,149
-8,088
| -17% | -$166K |
|
3534
BridgeBio Pharma
BBIO
$10B
| $822K | ﹤0.01% |
13,341
-5,777
| -30% | -$356K |
|
3535
The Bancorp
TBBK
$3.6B
| $821K | ﹤0.01% |
39,627
+14,581
| +58% | +$302K |
|
3536
Griffon
GFF
$3.53B
| $819K | ﹤0.01% |
30,122
-6,639
| -18% | -$181K |
|
|
QD
3537
Qudian
QD
$652M
| $819K | ﹤0.01% |
359,425
-313,082
| -47% | -$713K |
|
3538
Scansource
SCSC
$958M
| $819K | ﹤0.01% |
27,356
-171
| -0.6% | -$5.12K |
|
3539
Invesco S&P 100 Equal Weight ETF
EQWL
$1.71B
| $818K | ﹤0.01% |
10,876
+267
| +3% | +$20.1K |
|
3540
Surgery Partners
SGRY
$2.81B
| $818K | ﹤0.01% |
18,494
+7,250
| +64% | +$321K |
|
|
ATAXZ
3541
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $817K | ﹤0.01% |
147,667
-20,183
| -12% | -$112K |
|
|
DMB
3542
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$195M
| $815K | ﹤0.01% |
57,772
-9,445
| -14% | -$133K |
|
3543
Descartes Systems
DSGX
$8.75B
| $815K | ﹤0.01% |
13,376
+6,033
| +82% | +$368K |
|
3544
Viasat
VSAT
$4B
| $815K | ﹤0.01% |
16,964
-72,700
| -81% | -$3.49M |
|
3545
SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$921M
| $813K | ﹤0.01% |
26,966
-18,609
| -41% | -$561K |
|
3546
TriCo Bancshares
TCBK
$1.49B
| $811K | ﹤0.01% |
17,125
+6,221
| +57% | +$295K |
|
|
IGD
3547
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$472M
| $811K | ﹤0.01% |
142,289
+5,743
| +4% | +$32.7K |
|
|
PPT
3548
Putnam Premier Income Trust
PPT
$355M
| $811K | ﹤0.01% |
166,715
-40,706
| -20% | -$198K |
|
|
NGD
3549
New Gold Inc
NGD
$5.18B
| $808K | ﹤0.01% |
525,334
+42,296
| +9% | +$65.1K |
|
3550
SPDR S&P Insurance ETF
KIE
$752M
| $807K | ﹤0.01% |
22,013
+774
| +4% | +$28.4K |
|